Table 9.11a

Adjusted Patient Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	8,281	93.0%	0.3%	8,281	87.6%	0.4%	7,871	80.2%	0.5%	7,339	74.4%	0.5%
Primary Diagnosis	Non-Cholestatic Cirrhosis	5,456	93.3%	0.3%	5,456	87.6%	0.5%	5,336	79.1%	0.6%	4,763	73.2%	0.7%
	Cholestatic Liver Disease/Cirrhosis	824	94.9%	0.8%	824	91.7%	1.0%	837	86.8%	1.2%	991	83.1%	1.3%
	Acute Hepatic Necrosis	646	88.8%	1.3%	646	82.2%	1.6%	701	77.6%	1.6%	594	71.4%	2.0%
	Biliary Atresia	284	91.4%	2.4%	284	90.2%	2.6%	294	91.9%	1.9%	318	78.5%	3.5%
	Metabolic Diseases	288	93.5%	1.5%	288	90.4%	1.8%	264	83.6%	2.4%	279	80.7%	2.6%
	Malignant Neoplasms	397	94.9%	1.1%	397	87.4%	1.7%	164	65.3%	3.8%	169	58.8%	4.1%
	Other	386	89.1%	1.7%	386	84.3%	2.0%	275	78.1%	2.6%	225	67.7%	3.5%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.